Biblio

Author Title [ Type

] Year

Filters: Author is Hu, Zheng [Clear All Filters]

Journal Article

Jiang Y, Zhu C, He D, Gao Q, Tian X, Ma X, Wu J, Das BC, Severinov K, Hitzeroth IIsabel, et al. Cytological Immunostaining of HMGA2, LRP1B, and TP63 as Potential Biomarkers for Triaging Human Papillomavirus-Positive Women. Transl Oncol. 2019;12(7):959-967.

Ji T-T, Niu S-S, Fang M-H, Xu L-X, Wang X, Zou J, Xu F, Zhang M, Niu R, Wu J, et al. Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies. Cell Prolif. 2023:e13471.

Su Z, Liu Z, Lei W, Xia K, Xiao A, Hu Z, Zhou M, Zhu F, Tian J, Yang M, et al. Hyperhomocysteinemia lowers serum testosterone concentration via impairing testosterone production in Leydig cells. Cell Biol Toxicol. 2023.

Ren J, Yu D, Fu R, An P, Sun R, Wang Z, Guo R, Li H, Zhang Y, Li Z, et al. IL2RG-deficient minipigs generated via CRISPR/Cas9 technology support the growth of human melanoma-derived tumours. Cell Prolif. 2020:e12863.

Chen Y, Jiang H, Wang T, He D, Tian R, Cui Z, Tian X, Gao Q, Ma X, Yang J, et al. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system. Antiviral Res. 2020:104794.

Fang M, Zou J, Xu F, Wang X, Hua S, Zhou Q, Yang Y-G, Hu Z. Modeling human anti-pig xenoimmune responses in a pig artery tissue grafted humanized mouse model. Xenotransplantation. 2023:e12824.

Xia J, Hu Z, Yoshihara S, Li Y, Jin C-H, Tan S, Li W, Chen Q, Sykes M, Yang Y-G. Modeling Human Leukemia Immunotherapy in Humanized Mice. EBioMedicine. 2016.

Wang J, Mao K, Cong X, Tan H, Wu C, Hu Z, Yang Y-G, Sun T. Nanoparticle delivery of siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages. Sci Adv. 2022;8(51):eabq3699.